Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Esther Bernardo

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
Circulation. Cardiovascular Interventions|May 10, 2015
Impact of Intravenous Lysine Acetylsalicylate Versus Oral Aspirin on Prasugrel-Inhibited Platelets: Results of a Prospective, Randomized, Crossover Study (the ECCLIPSE Trial)David Vivas, Agustín Martín, Esther Bernardo, et al.
Heart (British Cardiac Society)|March 8, 2011
Effects of intensive glucose control on platelet reactivity in patients with acute coronary syndromes. Results of the CHIPS Study ("Control de Hiperglucemia y Actividad Plaquetaria en Pacientes con Sindrome Coronario Agudo")David Vivas, Juan C García-Rubira, Esther Bernardo, et al.
The Journal of Invasive Cardiology|May 25, 2004
Is a 300 mg clopidogrel loading dose sufficient to inhibit platelet function early after coronary stenting? A platelet function profile studyDominick J Angiolillo, Antonio Fernandez-Ortiz, Esther Bernardo, et al.
Journal of Thrombosis and Thrombolysis|May 27, 2011
Can resistance to aspirin be reversed after an additional dose?David Vivas, Esther Bernardo, Juan Carlos García-Rubira, et al.
European Heart Journal|November 4, 2004
High clopidogrel loading dose during coronary stenting: effects on drug response and interindividual variabilityDominick J Angiolillo, Antonio Fernández-Ortiz, Esther Bernardo, et al.
The International Journal of Cardiovascular Imaging|April 25, 2012
Morphological characteristics of culprit coronary lesions according to clinical presentation: insights from a multimodality imaging approachLorenzo Hernando, Cecilia Corros, Nieves Gonzalo, et al.
Journal of the American College of Cardiology|November 21, 2007
Intravascular ultrasound findings during episodes of drug-eluting stent thrombosisFernando Alfonso, Alfonso Suárez, María J Pérez-Vizcayno, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 19, 2004
807 C/T Polymorphism of the glycoprotein Ia gene and pharmacogenetic modulation of platelet response to dual antiplatelet treatmentDominick J Angiolillo, Antonio Fernandez-Ortiz, Esther Bernardo, et al.
European Heart Journal|July 23, 2005
LDL-cholesterol predicts negative coronary artery remodelling in diabetic patients: an intravascular ultrasound studyPilar Jiménez-Quevedo, Manel Sabaté, Dominick Angiolillo, et al.
Circulation|January 31, 2007
Randomized comparison of a high clopidogrel maintenance dose in patients with diabetes mellitus and coronary artery disease: results of the Optimizing Antiplatelet Therapy in Diabetes Mellitus (OPTIMUS) studyDominick J Angiolillo, Steven B Shoemaker, Bhaloo Desai, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Circulation. Cardiovascular Interventions|May 10, 2015
Impact of Intravenous Lysine Acetylsalicylate Versus Oral Aspirin on Prasugrel-Inhibited Platelets: Results of a Prospective, Randomized, Crossover Study (the ECCLIPSE Trial)David Vivas, Agustín Martín, Esther Bernardo, et al.
Heart (British Cardiac Society)|March 8, 2011
Effects of intensive glucose control on platelet reactivity in patients with acute coronary syndromes. Results of the CHIPS Study ("Control de Hiperglucemia y Actividad Plaquetaria en Pacientes con Sindrome Coronario Agudo")David Vivas, Juan C García-Rubira, Esther Bernardo, et al.
The Journal of Invasive Cardiology|May 25, 2004
Is a 300 mg clopidogrel loading dose sufficient to inhibit platelet function early after coronary stenting? A platelet function profile studyDominick J Angiolillo, Antonio Fernandez-Ortiz, Esther Bernardo, et al.
Journal of Thrombosis and Thrombolysis|May 27, 2011
Can resistance to aspirin be reversed after an additional dose?David Vivas, Esther Bernardo, Juan Carlos García-Rubira, et al.
European Heart Journal|November 4, 2004
High clopidogrel loading dose during coronary stenting: effects on drug response and interindividual variabilityDominick J Angiolillo, Antonio Fernández-Ortiz, Esther Bernardo, et al.
The International Journal of Cardiovascular Imaging|April 25, 2012
Morphological characteristics of culprit coronary lesions according to clinical presentation: insights from a multimodality imaging approachLorenzo Hernando, Cecilia Corros, Nieves Gonzalo, et al.
Journal of the American College of Cardiology|November 21, 2007
Intravascular ultrasound findings during episodes of drug-eluting stent thrombosisFernando Alfonso, Alfonso Suárez, María J Pérez-Vizcayno, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 19, 2004
807 C/T Polymorphism of the glycoprotein Ia gene and pharmacogenetic modulation of platelet response to dual antiplatelet treatmentDominick J Angiolillo, Antonio Fernandez-Ortiz, Esther Bernardo, et al.
European Heart Journal|July 23, 2005
LDL-cholesterol predicts negative coronary artery remodelling in diabetic patients: an intravascular ultrasound studyPilar Jiménez-Quevedo, Manel Sabaté, Dominick Angiolillo, et al.
Circulation|January 31, 2007
Randomized comparison of a high clopidogrel maintenance dose in patients with diabetes mellitus and coronary artery disease: results of the Optimizing Antiplatelet Therapy in Diabetes Mellitus (OPTIMUS) studyDominick J Angiolillo, Steven B Shoemaker, Bhaloo Desai, et al.
Pageof 5